CD5 and mature T-cell and NK-cell non-Hodgkin lymphoma: Currently, eight different markers are being tested as targets for CAR therapy for PTCL: CD4, CD5, CD7, CD30, CD37, CD70, CD147 and TRBC1 (Table 3).